Renaissance Technologies »

Atara Biotherapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Atara Biotherapeutics shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-06-30 $392k 46k 8.50

More positions owned by Renaissance Technologies

Novo-nordisk A S Adr (NVO)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Vertex Pharmaceuticals Incorporated (VRTX)
United Therapeutics Corporation (UTHR)
Verisign (VRSN)
Meta Platforms Cl A (META)
Airbnb Com Cl A (ABNB)
Broadcom (AVGO)
Tesla Motors (TSLA)
Sprouts Fmrs Mkt (SFM)
Franco-Nevada Corporation (FNV)
Apple (AAPL)
Gilead Sciences (GILD)
Exelixis (EXEL)

View all positions for Renaissance Technologies

Top funds holding Atara Biotherapeutics

Redmile Group
EcoR1 Capital
Citadel Advisors
Bank of America Corporation
Vanguard Group
Centiva Capital
Acadian Asset Management
Millennium Management
Vestal Point Capital
Qube Research & Technologies
Tang Capital Management
Woodline Partners
BlackRock
Renaissance Technologies
Geode Capital Management

View all funds holding Atara Biotherapeutics